Leukocytoclastic vasculitis as a cutaneous manifestation of ChAdOx1 nCoV‐19 corona virus vaccine (recombinant)

With the present COVID‐19 vaccination drive across the world, adverse skin reactions post COVID‐19 vaccine is expected. Majority of these reactions seen were transient or local injection site reactions. However, as the larger population is being vaccinated, certain uncommon dermatological presentati...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Dermatologic therapy 2021-11, Vol.34 (6), p.e15141-n/a
Hauptverfasser:	Sandhu, Sunmeet, Bhatnagar, Anuj, Kumar, Harish, Dixit, Prashant Kumar, Paliwal, Gourang, Suhag, Devinder Kumar, Patil, Chetan, Mitra, Debdeep
Format:	Artikel
Sprache:	eng
Schlagworte:	2019-nCoV Vaccine mRNA-1273 BNT162 Vaccine ChAdOx1 nCoV-19 corona virus vaccine (recombinant) COVID-19 COVID-19 Vaccines COVID‐19 vaccination Humans leukocytoclastic vasculitis SARS-CoV-2 Short Paper Short Reports Skin Diseases Vasculitis, Leukocytoclastic, Cutaneous
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!